Literature DB >> 3666562

H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?

D A Robertson1, M A Aldersley, H Shepherd, R S Lloyd, C L Smith.   

Abstract

Ambulatory oesophageal pH, oesophageal manometry and fasting serum gastrin concentrations were carried out on 28 patients with reflux oesophagitis, before and during treatment with ranitidine 300 mg bd. Fourteen patients healed endoscopically at six weeks (group A) and 14 had residual oesophagitis (group B). Group A were characterised by a lower serum gastrin concentration before treatment (4.52 pmol/l; 2.4-10: mean and range) than group B (11.1 pmol/l; 3.5-21: p less than 0.05) and showed a marked reduction in acid reflux on treatment to near normal values. Mean per cent time below pH4 fell from 14.9 to 4.2 in group A (p less than 0.05) but was not affected in group B (14.2-15.6, not significant). Abnormal oesophageal motility was found in 13 patients from each group. This did not inhibit the response to ranitidine, and was not improved by healing of oesophagitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666562      PMCID: PMC1433151          DOI: 10.1136/gut.28.8.946

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Motility disturbances caused by esophagitis.

Authors:  A M Olsen; J F Schlegel
Journal:  J Thorac Cardiovasc Surg       Date:  1965-11       Impact factor: 5.209

2.  Treatment of reflux oesophagitis.

Authors:  I C Wesdorp
Journal:  Scand J Gastroenterol Suppl       Date:  1982

3.  A frequency-duration index (FDI) for the evaluation of ambulatory recordings of gastro-oesophageal reflux.

Authors:  F J Branicki; D F Evans; J A Jones; A L Ogilvie; M Atkinson; J D Hardcastle
Journal:  Br J Surg       Date:  1984-06       Impact factor: 6.939

4.  Effect of cimetidine on lower oesophageal sphincter pressure in oesophagitis.

Authors:  R J Goodall; J G Temple
Journal:  Br Med J       Date:  1980-03-01

5.  The mechanism of action of gastrin on the lower esophageal sphincter.

Authors:  S Rattan; D Coln; R K Goyal
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

6.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring.

Authors:  T R DeMeester; C I Wang; J A Wernly; C A Pellegrini; A G Little; P Klementschitsch; G Bermudez; L F Johnson; D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1980-05       Impact factor: 5.209

7.  The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux.

Authors:  S M Fink; R W McCallum
Journal:  JAMA       Date:  1984-09-07       Impact factor: 56.272

8.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

9.  Esophageal motor abnormalities in gastroesophageal reflux and the effects of fundoplication.

Authors:  R C Gill; K L Bowes; P D Murphy; Y J Kingma
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

  9 in total
  11 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.

Authors:  T Sekiguchi; T Nishioka; T Matsuzaki; M Sugiyama; M Kusano; T Horikoshi; M Toki; T Ohwada; S Kobayashi
Journal:  Gastroenterol Jpn       Date:  1991-04

Review 3.  Histamine-2-receptor antagonists in gastro-oesophageal reflux.

Authors:  D G Colin-Jones
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

Review 4.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease.

Authors:  J M Marrero; J S de Caestecker; J D Maxwell
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 6.  Alkaline reflux oesophagitis.

Authors:  D L Stoker; J G Williams
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

7.  Composition of gastro-oesophageal refluxate.

Authors:  D C Gotley; A P Morgan; D Ball; R W Owen; M J Cooper
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

8.  Healing and prevention of relapse of reflux oesophagitis by cisapride.

Authors:  J Toussaint; A Gossuin; M Deruyttere; F Hublé; G Devis
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

9.  Patterns of acid reflux in complicated oesophagitis.

Authors:  D Robertson; M Aldersley; H Shepherd; C L Smith
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

Review 10.  Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.

Authors:  N J Bell; R H Hunt
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.